← FDA Drug Approvals (Drugs@FDA)
XADAGO
NDA · New Drug Application · Sponsor: MDD US · Approved 2017-03-21
Drug application
- FDA Application #
NDA207145- Application type
- New Drug Application
- Brand name
- XADAGO
- Generic name
- SAFINAMIDE MESYLATE
- Active ingredients
- SAFINAMIDE MESYLATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MDD US
- Manufacturer
- MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
- First approval
- 2017-03-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown